Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Why Okta Shares Are Trading Higher By Around 14%; Here Are 27 Stocks Moving Premarket

Published 01/12/2022, 11:16
Updated 01/12/2022, 12:40
© Reuters.  Why Okta Shares Are Trading Higher By Around 14%; Here Are 27 Stocks Moving Premarket

Benzinga - Gainers

  • Pacifico Acquisition Corp. (NASDAQ: PAFO) shares rose 40.9% to $7.58 in pre-market trading after dipping around 43% on Wednesday.
  • Otonomy, Inc. (NASDAQ: OTIC) rose 17.1% to $0.2101 in pre-market trading after dropping around 22% on Wednesday. Otonomy recently posted a Q3 loss of $0.18 per share.
  • Kalera Public Limited Company (NASDAQ: KAL) shares rose 14.6% to $0.1719 in pre-market trading after dropping around 17% on Wednesday. Kalera recently announced restructuring process for German subsidiary.
  • Okta, Inc. (NASDAQ: OKTA) rose 13.8% to $60.67 in pre-market trading after the company reported better-than-expected Q3 results. The company also issued Q4 and FY23 EPS and sales guidance above analyst estimates.
  • Sonim Technologies, Inc. (NASDAQ: SONM) rose 13.7% to $0.4697 in pre-market trading. Sonim Technologies announced $17 million additional tablet order.
  • American Rebel Holdings, Inc. (NASDAQ: AREB) rose 13.6% to $0.2787 in pre-market trading after dropping 15% on Wednesday. American Rebel Holdings recently posted a Q3 loss of $0.36 per share.
  • Ra Medical Systems, Inc. (NYSE: RMED) rose 11.8% to $2.74 in pre-market trading after jumping 16% on Wednesday. Ra Medical recently posted a Q3 loss of $4.36 per share.
  • Eos Energy Enterprises, Inc. (NASDAQ: EOSE) rose 10.4% to $1.17 in pre-market trading. Eos Energy recently reported worse-than-expected Q3 EPS and sales results.
  • Missfresh Limited (NASDAQ: MF) shares rose 10.4% to $1.70 in pre-market trading.
  • MEI Pharma, Inc. (NASDAQ: MEIP) rose 10.2% to $0.3750 in pre-market trading. Kyowa Kirin and MEI Pharma recently announced topline data from the Phase 2 MIRAGE study evaluating Zandelisib in patients with Indolent B-cell non-Hodgkin's Lymphoma in Japan.
  • Athenex, Inc. (NASDAQ: ATNX) rose 9.5% to $0.23 in pre-market trading after jumping around 22% on Wednesday.
  • Splunk Inc. (NASDAQ: SPLK) rose 9.2% to $84.84 in pre-market trading after the company reported better-than-expected results for its third quarter and raised FY23 sales guidance.
  • Guardforce AI Co., Limited (NASDAQ: GFAI) rose 8.3% to $0.2094 in pre-market trading.
  • Lordstown Motors Corp. (NASDAQ: RIDE) gained 6.6% to $1.77 in pre-market trading after jumping 16% on Wednesday. Lordstown Motors said its Endurance pickup truck achieved full homologation, EPA and CARB certification has been received and first customer vehicles are leaving the Foxconn EV Ohio plant for delivery.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Losers

  • G-III Apparel Group, Ltd. (NASDAQ: GIII) fell 26.6% to $15.88 in pre-market trading after the company reported downbeat Q3 earnings and issued weak earnings forecast.
  • Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares fell 26.1% to $0.10 in pre-market trading after declining over 7% on Wednesday. Panbela recentlys said first patients enrolled in Europe for ASPIRE trial studying Ivospemin (SBP-101) in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma.
  • Winc, Inc. (NYSE: WBEV) fell 19% to $0.24 in pre-market trading. Winc recently posted a Q3 loss of $0.33 per share.
  • Biodesix, Inc. (NASDAQ: BDSX) shares fell 19% to $1.62 in pre-market trading after surging 47% on Wednesday.
  • Aziyo Biologics, Inc. (NASDAQ: AZYO) fell 16.7% to $5.75 in pre-market trading after the company reported a proposed public offering of common stock.
  • Elastic N.V. (NYSE: ESTC) fell 15.2% to $51.89 in pre-market trading after the company posted upbeat Q2 results and issued strong earnings forecast.
  • Myomo, Inc. (NYSE: MYO) shares fell 13.8% to $0.6999 in pre-market trading after gaining 33% on Wednesday. The company recently posted upbeat quarterly results.
  • Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) fell 10.3% to $0.1744 in pre-market trading after jumping 60% on Wednesday.
  • Cognition Therapeutics, Inc. (NASDAQ: CGTX) shares fell 10% to $3.16 in pre-market trading after jumping over 41% on Wednesday.
  • Credit Suisse (SIX:CSGN) Group AG (NYSE: CS) fell 8.2% to $3.01 in pre-market trading. The company recently said it expects to post a loss for the quarter. Shareholders last week also approved the company's capital raise plan.
  • XPeng Inc. (NYSE: XPEV) fell 8.2% to $9.92 in pre-market trading. XPeng shares jumped over 47% on Wednesday after reporting quarterly results.
  • Salesforce, Inc. (NYSE: CRM) shares fell 6.2% to $150.34 in pre-market trading after the company reported third-quarter results and announced that Bret Taylor will step down as vice chair and co-CEO.
  • Snowflake Inc. (NASDAQ: SNOW) shares fell 5.3% to $135.29 in pre-market trading after the company reported Q3 financial results and issued product revenue guidance.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.